GLP-1 medicines and changes in the face
Rapid weight loss shows in the face early. Why that happens, and what is worth doing about it, including waiting.

Perspective from Stone Surgical Arts
People losing weight quickly on GLP-1 medicines often notice the change in their face before anywhere else, and are sometimes unsettled by it.
A thought to keep
Let the weight stabilise before deciding on facial treatment. Faces continue to change while the weight is still moving.
01
Why the face changes
The face holds distinct compartments of fat that give it fullness and support the overlying skin. Substantial weight loss reduces that volume, and because the face has little spare skin, the loss shows as hollowing and as folds becoming more apparent.
The effect is more noticeable when loss is rapid, and more noticeable with age, as skin elasticity is lower and recovers less.
02
It is not a side effect of the drug
The change reflects the weight loss rather than a specific action of the medicine on the face. The same appears after rapid loss by any means.
That matters, because it makes it a question about timing and about the rate of loss, which a prescriber can discuss with you.
03
What can be done
The first advice is to wait. Faces continue to change while weight is still moving, and treatment planned mid-course often needs revisiting.
Once weight is stable, options range from restoring volume with fillers or fat, to skin treatments, to surgery where laxity is the dominant issue. Which is appropriate depends on how much of the change is volume and how much is skin.
04
Doing it safely
Keep the prescriber informed, particularly about any planned procedure, since these medicines slow gastric emptying and that is relevant to sedation and anaesthesia. Tell your surgeon or anaesthetist you are taking one.
Buy only through a regulated route. The FDA has warned about unapproved and compounded versions where the contents and dose may not be as claimed.
Adapted from the Stone Surgical Arts archive and updated for clarity. This article offers general information; an individual consultation is needed for treatment advice.
Further reading
FDA: concerns with unapproved GLP-1 drugs used for weight loss NIDDK: weight management

